[Federal Register Volume 81, Number 109 (Tuesday, June 7, 2016)]
[Notices]
[Pages 36543-36544]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13438]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Candidates To Serve on the Clinical
Laboratory Improvement Advisory Committee (CLIAC) and Request for
Suggested Meeting Topics for CLIAC
The Centers for Disease Control and Prevention (CDC) is soliciting
nominations for membership on CLIAC and soliciting suggestions for
topics to be considered for future Committee deliberation. CLIAC
provides scientific and technical advice and guidance to the Secretary,
Department of Health and Human Services (HHS); the Assistant Secretary
for Health, HHS; the Director, Centers for Disease Control and
Prevention (CDC); the Commissioner, Food and Drug Administration (FDA);
and the Administrator, Centers for Medicare & Medicaid Services (CMS).
The advice and guidance pertain to general issues related to
improvement in clinical laboratory quality and laboratory medicine. In
addition, the Committee provides advice and guidance on specific
questions related to possible revision of the CLIA standards. Examples
include providing guidance on studies designed to improve safety,
effectiveness, efficiency, timeliness, equity, and patient-centeredness
of laboratory services; revisions to the standards under which clinical
laboratories are regulated; the impact of proposed revisions to the
standards on medical and laboratory practice; and the modification of
the standards and provision of non-regulatory guidelines to accommodate
technological advances, such as new test methods, the electronic
transmission of laboratory information, and mechanisms to improve the
integration of public health and clinical laboratory practices.
CLIAC consists of 20 members including the Chair, and represents a
diverse membership across laboratory specialties, professional roles
(laboratory management, technical specialists, physicians, nurses) and
practice settings (academic, clinical, public health), and includes a
consumer representative. In addition, the Committee includes three ex
officio members (or designees), including the Director, CDC; the
Administrator, CMS; and the Commissioner, FDA. A nonvoting
representative from the Advanced Medical Technology Association
(AdvaMed) serves as the industry liaison. The Designated Federal
Officer (DFO) or their designee and the Executive Secretary are present
at all meetings to ensure meetings are within applicable statutory,
regulatory and HHS General Administration manual directives.
Request for Candidates: Nominations are being sought for
individuals who have expertise and qualifications necessary to
contribute to accomplishing CLIAC's objectives. Nominees will be
selected by the HHS Secretary or designee from authorities
knowledgeable across the fields of microbiology (including
bacteriology, mycobacteriology, mycology, parasitology, and virology),
immunology (including histocompatibility), chemistry, hematology,
pathology (including histopathology and cytology), or genetic testing
(including cytogenetics); representatives from the fields of medical
technology, public health, and clinical practice; and consumer
representatives. Members may be invited to serve for terms of up to
four years.
The U.S. Department of Health and Human Services policy stipulates
that Committee membership be balanced in terms of professional training
and background, points of view represented, and the committee's
function. Consideration is given on the basis of geographic, ethnic and
gender representation. Nominees must be U.S. citizens, and cannot be
full-time employees of the U.S. Government. Current participation on
federal workgroups or prior experience serving on a federal advisory
committee does not disqualify a candidate; however, HHS policy is to
avoid excessive individual service on advisory committees and multiple
committee memberships. Committee members are Special Government
Employees, requiring the filing of financial disclosure reports at the
beginning and annually during their terms. CDC reviews potential
candidates for CLIAC membership each year, and provides a slate of
nominees for consideration to the Secretary of HHS for final selection.
HHS notifies selected candidates of their appointment near the start of
the term in July, or as soon as the HHS selection process is completed.
Note that the need for different expertise and individuals to maintain
the appropriate demographic balance varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year.
Candidates should submit the following items to be considered for
nomination. The deadline for receipt of materials for the 2017 term is
August 1, 2016:
Current curriculum vitae, including complete contact
information (name, affiliation, mailing address, telephone number,
email address).
Letter(s) of recommendation from person(s) not employed by
the U.S. Department of Health and Human Services.
Request for Suggested Meeting Topics: Consideration of topics for
meeting agendas begins approximately four months prior to each meeting.
The agendas are developed by CDC in collaboration with CMS, FDA, and
the CLIAC Chair. Topics within the scope of
[[Page 36544]]
the Committee's charge are selected and questions for CLIAC
deliberation are developed to align with the agenda. The agenda is
published in the Federal Register not less than 15 days before the
meeting date and is posted on the CLIAC Web site (http://wwwn.cdc.gov/cliac/default.aspx). Suggested meeting topics are invited at any time
for consideration at future meetings.
Submission of Candidate Information or Suggestions for Meeting
Topics: Candidate suggestions and potential meeting topics may be
submitted by:
Email in care of the CLIAC Secretariat at [email protected].
U.S. Postal Service: Attention: CLIAC Secretariat, 1600
Clifton Road NE., Mailstop F-11, Atlanta, GA 30329.
Contact Person for Additional Information: Nancy Anderson, Chief,
Laboratory Practice Standards Branch, Division of Laboratory Systems,
Center for Surveillance, Epidemiology and Laboratory Services, Office
of Public Health Scientific Services, Centers for Disease Control and
Prevention, 1600 Clifton Road NE., Mailstop F-11, Atlanta, Georgia
30329-4018; telephone (404) 498-2741; or via email at
[email protected]. The Director, Management Analysis and Services
Office, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities for both the Centers for Disease Control and
Prevention, and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-13438 Filed 6-6-16; 8:45 am]
BILLING CODE 4163-18-P